Evidence map›Paper›PMID 30622218›Full record

ArticleEMBO reports2019

Keisuke Hitachi, Masashi Nakatani, Akihiko Takasaki, Yuya Ouchi, Akiyoshi Uezumi, Hiroshi Ageta, Hidehito Inagaki, Hiroki Kurahashi, Kunihiro Tsuchida

Open access · bronzeAbstract read
In one paragraph

Article in EMBO reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. A causal SNP in the promoter ofZoological research · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Epigenetics of Skeletal Muscle Atrophy.International journal of molecular sciences · 2024
    Review
  10. Article
  11. LncRNAInternational journal of molecular sciences · 2023
    Article
  12. Article
  13. Article
  14. Regulation of muscle stem cell fate.Cell regeneration (London, England) · 2022
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Identification of atrial-enriched lncRNA Walras linked to cardiomyocyte cytoarchitecture and atrial fibrillation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  20. International journal of molecular sciences · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Keisuke HitachiDivision for Therapies against Intractable Diseases, Institute for Comprehensive Medical Science (ICMS), Fujita Health University, Toyoake, Japan.
Masashi NakataniDivision for Therapies against Intractable Diseases, Institute for Comprehensive Medical Science (ICMS), Fujita Health University, Toyoake, Japan.
Akihiko TakasakiDepartment of Medical Technology, School of Health Sciences, Gifu University of Medical Science, Seki, Japan.
Yuya OuchiGenome and Transcriptome Analysis Center, Fujita Health University, Toyoake, Japan.
Akiyoshi UezumiDivision for Therapies against Intractable Diseases, Institute for Comprehensive Medical Science (ICMS), Fujita Health University, Toyoake, Japan.
Hiroshi AgetaDivision for Therapies against Intractable Diseases, Institute for Comprehensive Medical Science (ICMS), Fujita Health University, Toyoake, Japan.
Hidehito InagakiGenome and Transcriptome Analysis Center, Fujita Health University, Toyoake, Japan.
Hiroki KurahashiGenome and Transcriptome Analysis Center, Fujita Health University, Toyoake, Japan.
Kunihiro TsuchidaDivision for Therapies against Intractable Diseases, Institute for Comprehensive Medical Science (ICMS), Fujita Health University, Toyoake, Japan tsuchida@fujita-hu.ac.jp.ORCID 0000-0002-3983-5756
Fujita Health University · JPGifu University of Medical Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Promoter-associated long non-coding RNAs (lncRNAs) regulate the expression of adjacent genes; however, precise roles of these lncRNAs in skeletal muscle remain largely unknown. Here, we characterize a promoter-associated lncRNA,

Indexed as

Promoter Regions, GeneticAnimalsCell CycleCell DifferentiationCell LineDEAD-box RNA HelicasesGene Expression Regulation, DevelopmentalHumansMice, Inbred C57BLModels, BiologicalMuscle DevelopmentMuscle, SkeletalMuscular AtrophyMyoblastsMyoD ProteinMyogeninDEAD-box RNA HelicasesMyoD ProteinMyogeninp300-CBP-Associated Factorp300-CBP Transcription FactorsRNA, Long NoncodingTransforming Growth Factor betachromatinDEAD box proteinmyogenesistranscriptional regulation

Identifiers

PMID30622218
PMCPMC6399612
OpenAlexW2910530872

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.